Citation Tools
PDFRegular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
514 Development of AIM-104, a potential best-in-class pan-allele anti-SIRPα antibody for anti-tumor therapy
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 514 Development of AIM-104, a potential best-in-class pan-allele anti-SIRPα antibody for anti-tumor therapy